{"database": "openregs", "table": "federal_register", "rows": [["2017-26013", "Receipt of Notice That a Patent Infringement Complaint Was Filed Against a Biosimilar Applicant", "Notice", "The Food and Drug Administration (FDA) is publishing notice that an applicant for a proposed biosimilar product notified FDA that a patent infringement action was filed in connection with the applicant's biologics license application (BLA). Under the Public Health Service Act (PHS Act), an applicant for a proposed biosimilar product or interchangeable product must notify FDA within 30 days after the applicant was served with a complaint in a patent infringement action described under the PHS Act. FDA is required to publish notice of the complaint in the Federal Register.", "2017-12-04", 2017, 12, "https://www.federalregister.gov/documents/2017/12/04/2017-26013/receipt-of-notice-that-a-patent-infringement-complaint-was-filed-against-a-biosimilar-applicant", "https://www.govinfo.gov/content/pkg/FR-2017-12-04/pdf/2017-26013.pdf", "Health and Human Services Department; Food and Drug Administration", "221,199", "The Food and Drug Administration (FDA) is publishing notice that an applicant for a proposed biosimilar product notified FDA that a patent infringement action was filed in connection with the applicant's biologics license application (BLA). Under the...", null]], "columns": ["document_number", "title", "type", "abstract", "publication_date", "pub_year", "pub_month", "html_url", "pdf_url", "agency_names", "agency_ids", "excerpts", "regulation_id_numbers"], "primary_keys": ["document_number"], "primary_key_values": ["2017-26013"], "units": {}, "query_ms": 50.100223859772086, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}